As reported in Israel 21C: A pioneer in online and smart phone mapping, Israel’s Telmap navigation tools are used by half the smart phone users in Europe and the Middle East. One of the things that make smart phones smart is their ability to help you to get where you’re going, using navigation maps. Navigation […]
Category: Latest News Israel
TEMPUS, a European Union program aimed at supporting higher education in neighboring countries, awarded Israel’s Sami Shamoon Academic College of Engineering (SCE) a 1 million Euro grant to teach innovation. SCE will lead a group of 18 institutions and companies from both within and outside Israel, including Apple’s Israeli representative E-Digital, SIT, and the Interdisciplinary […]
As reported in Globes: Stanley Fischer told “Globes” that if speculators think that he is maintaining the exchange rate at NIS 3.80/$, then they are wrong. On the eve of Rosh Hashana 5771, Governor of the Bank of Israel Prof. Stanley Fischer spoke with “Globes”. “Globes”: There is a lot of criticism about your foreign currency […]
Categories
CBS Predicts 4.1% Growth
As reported in Globes: The Central Bureau of Statistics forecast for 2010 is higher than the Bank of Israel’s prediction of 3.7%. The Central Bureau of Statistics predicts that Israel’s GDP will grow by 4.1% in 2010 compared with 0.8% in 2009. The Central Bureau of Statistics issued the prediction to mark publication today of “Selected […]
As reported in Globes: CEO Prof. Pnina Fishman: The treatment positions the company in the forefront of drug development for dry-eye syndrome. Can-Fite BioPharma Ltd. has obtained US Food and Drug Administration (FDA) approval for the Phase III clinical trial of its CF101 anti-inflammatory drug for the treatment of dry-eye syndrome. The trial will last for […]
In order to encourage large financial services companies and international banks to set up financial R&D centers in Israel, the Ministry of Finance and the Ministry of Industry, Trade, and Labor have established a special incentives program. The government will provide 40% of the plan’s total budget approved by the Office of the Chief Scientist […]
Categories
The Gene at the Heart of Pain
As reported in Israel 21C: A gene affecting chronic pain caused by nerve injury has been identified by Israeli and international researchers, opening the way for new treatment approaches. A gene associated with susceptibility to chronic pain caused by nerve injury in humans has been identified by a team of Israeli and international researchers, offering […]
Medical product giant Baxter International and Israeli biopharmaceutical company Kamada entered into a definitive distribution agreement for Glassia, the first and only liquid, ready-to-use Alpha1-Proteinase inhibitor that treats genetic lung-damaging disorder alpha-1 antitryspin (AAT). Baxter has committed to buying minimum quantities of Glassia worth around $60 million, and has secured exclusive marketing rights to Kamada’s […]
Privately held Quark Pharmaceuticals Inc licensed its experimental kidney drug to Swiss giant Novartis in a multi-million dollar deal. Novartis obtained the exclusive worldwide license to Quark’s experimental drug QPI-1002 for an upfront payment of $10 million, followed by a slate of milestone payments that could reach as high as $670 million based on developmental […]
From Port2Port: This year that date falls on the afternoon of 8th September 2010 and continues until the evening of 10th September 2010, which is also Sabbath eve The Jewish New Year is celebrated on the first and second days of the Hebrew month of Tishrei. This year that date falls on the afternoon of […]
israeltrade.org.au 